U.S. markets open in 3 hours 6 minutes

InMed Pharmaceuticals Inc. (IN.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
5.46-0.46 (-7.77%)
At close: 3:59PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.92
Open5.97
Bid5.46 x N/A
Ask5.49 x N/A
Day's Range5.44 - 6.05
52 Week Range0.30 - 13.69
Volume22,275
Avg. Volume36,914
Market Cap43.957M
Beta (5Y Monthly)2.24
PE Ratio (TTM)N/A
EPS (TTM)-1.44
Earnings DateFeb 11, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • InMed Announces Closing of US$4.5 Million Private Placement
      CNW Group

      InMed Announces Closing of US$4.5 Million Private Placement

      16, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ("CBN"), today announced that it has closed the previously announced private placement.

    • ACCESSWIRE

      InMed Pharmaceuticals, Inc. to Host Earnings Call

      NEW YORK, NY / ACCESSWIRE / February 11, 2021 / InMed Pharmaceuticals, Inc. (TSX:IN) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 11, 2021 at 11:30 AM Eastern Time.

    • InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results
      PR Newswire

      InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results

      InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol ("CBN"), today reported financial results for the second quarter of fiscal year 2021 ("2Q21") which ended December 31, 2020.